InjectionClinical Overview
Diazepam is a prototype long-acting 1,4-benzodiazepine on the WHO Model List of Essential Medicines. It binds to the GABAA receptor complex in the limbic system, thalamus, and hypothalamus, facilitating GABA-mediated inhibitory neurotransmission. Possesses an active desmethyldiazepam metabolite with a prolonged elimination half-life (up to 100 hours). Indicated for management of anxiety disorders, acute alcohol withdrawal syndrome (delirium tremens), skeletal muscle spasm, and status epilepticus.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Administered by a licensed healthcare professional by slow intravenous injection (no faster than 5 mg/min) into a large vein, or deep intramuscular injection. Have emergency respiratory support equipment immediately accessible.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Drowsiness, fatigue, muscle weakness, ataxia, lightheadedness. Rare/Severe: Boxed warning: Respiratory arrest, profound sedation and coma (with opioids/alcohol), dependence and severe withdrawal syndrome (delirium, convulsions), and paradoxical excitation.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Black box warnings for abuse, misuse, dependence, and severe risks when combined with opioids. Contraindicated in myasthenia gravis, severe respiratory failure, acute narrow-angle glaucoma, and sleep apnea.
Schedule H1 (Prescription Required - Habit Forming Warning)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Diazepam Tablets 5 mg
Diazepam is a prototype long-acting 1,4-benzodiazepine on the WHO Model List of Essential Medicines. It binds to the GABAA receptor complex in the limbic system, thalamus, and hypothalamus, facilitating GABA-mediated inhibitory neurotransmission. Possesses an active desmethyldiazepam metabolite with a prolonged elimination half-life (up to 100 hours). Indicated for management of anxiety disorders, acute alcohol withdrawal syndrome (delirium tremens), skeletal muscle spasm, and status epilepticus.
Diazepam Tablets 2 mg
Diazepam is a prototype long-acting 1,4-benzodiazepine on the WHO Model List of Essential Medicines. It binds to the GABAA receptor complex in the limbic system, thalamus, and hypothalamus, facilitating GABA-mediated inhibitory neurotransmission. Possesses an active desmethyldiazepam metabolite with a prolonged elimination half-life (up to 100 hours). Indicated for management of anxiety disorders, acute alcohol withdrawal syndrome (delirium tremens), skeletal muscle spasm, and status epilepticus.
Diazepam Tablets 10 mg
Diazepam is a prototype long-acting 1,4-benzodiazepine on the WHO Model List of Essential Medicines. It binds to the GABAA receptor complex in the limbic system, thalamus, and hypothalamus, facilitating GABA-mediated inhibitory neurotransmission. Possesses an active desmethyldiazepam metabolite with a prolonged elimination half-life (up to 100 hours). Indicated for management of anxiety disorders, acute alcohol withdrawal syndrome (delirium tremens), skeletal muscle spasm, and status epilepticus.
Imipramine + Diazepam Tablet (25/2 Mg)
Diazepam and Imipramine combines a classical long-acting benzodiazepine with a tricyclic antidepressant (TCA). Imipramine blocks reuptake of norepinephrine and serotonin to treat depression, while diazepam immediately quells panic, anxiety, motor agitation, and insomnia. Indicated for depression accompanied by pronounced anxiety, agitation, or sleep architecture disruption.